Flutterby™! : Experimenting without consent

Next unread comment / Catchup all unread comments User Account Info | Logout | XML/Pilot/etc versions | Long version (with comments) | Weblog archives | Site Map | | Browse Topics

Experimenting without consent

2020-04-11 18:27:29.998232+00 by Dan Lyke 2 comments

COVID-19 Patients Given Unproven Drug In Texas Nursing Home In 'Disconcerting' Move

He acknowledged that some families were not aware their relatives were put on the drug, saying that "for the most part," he consulted with each nursing home resident prior to giving them on the tablets.

While the "overwhelming majority of them are awake and alert and can actually have a conversation," Armstrong said some suffer from middle stages of dementia. In some cases, he did not discuss prescribing the tablets with anyone at all before doing so. He said it is common for physicians to prescribe new medications to patients without explicit consent from the patient or family members. "It's not required," he said.

Ignoring the fact that the "study" design is total crap, Cassandra, Irredeemable Pudgy Nobody @ChrisWarcraft points out that "We hanged Nazis for doing this."

[ related topics: Health Invention and Design Sociology Graphic Design ]

comments in ascending chronological order (reverse):

#Comment Re: Experimenting without consent made: 2020-04-13 22:27:47.165598+00 by: stevesh

From an article on scpr.org:

The 1987 approval of azidothymidine — AZT — as the first AIDS medicine, was a game-changer for the FDA, he says. The agency approved AZT without waiting for the long clinical trials required in other drug approvals. It did this on condition that the drugmaker, Burroughs Wellcome, would continue to study patients taking the drug, and report the results back to the FDA. That decision by the agency has paved the way for accelerated approval pathways for other drugs.

#Comment Re: Experimenting without consent made: 2020-04-14 18:02:23.247735+00 by: Dan Lyke

Yeah, pretty sure those AZT patients had informed consent.

Add your own comment:

(If anyone ever actually uses Webmention/indie-action to post here, please email me)

Format with:

(You should probably use "Text" mode: URLs will be mostly recognized and linked, _underscore quoted_ text is looked up in a glossary, _underscore quoted_ (http://xyz.pdq) becomes a link, without the link in the parenthesis it becomes a <cite> tag. All <cite>ed text will point to the Flutterby knowledge base. Two enters (ie: a blank line) gets you a new paragraph, special treatment for paragraphs that are manually indented or start with "#" (as in "#include" or "#!/usr/bin/perl"), "/* " or ">" (as in a quoted message) or look like lists, or within a paragraph you can use a number of HTML tags:

p, img, br, hr, a, sub, sup, tt, i, b, h1, h2, h3, h4, h5, h6, cite, em, strong, code, samp, kbd, pre, blockquote, address, ol, dl, ul, dt, dd, li, dir, menu, table, tr, td, th

Comment policy

We will not edit your comments. However, we may delete your comments, or cause them to be hidden behind another link, if we feel they detract from the conversation. Commercial plugs are fine, if they are relevant to the conversation, and if you don't try to pretend to be a consumer. Annoying endorsements will be deleted if you're lucky, if you're not a whole bunch of people smarter and more articulate than you will ridicule you, and we will leave such ridicule in place.

Flutterby™ is a trademark claimed by

Dan Lyke
for the web publications at www.flutterby.com and www.flutterby.net.